Expert Rev Anticancer Ther
January 2025
Background: The hemoglobin, albumin, lymphocyte, and platelet (HALP) score could be a prognostic biomarker in patients with cancer as a reflector of nutritional and inflammatory status, although the data is limited in patients treated with immune-checkpoint inhibitors (ICIs). Therefore, we sought to investigate the relationship between HALP score and survival in ICI-treated patients.
Methods: We included adult patients with advanced cancer treated with ICIs between June 2016 and January 2024.
Objective: Age determination aims to determine an individual's physiological age without information about the individual's chronological age (CA) or in forensic situations in a way that does not cause loss of legal rights. The study aimed to evaluate the suitability of Cameriere (CM), Modified Cameriere (MCM) for Turkish children, Willems (WM), and Blenkin-Evans methods (BEM) for Turkish children.
Design: A total of 616 Panoramic images of 321 female and 295 male healthy children from the Central Anatolia region aged between 6 and 14.
Objective: The recent outbreak of monkeypox (mpox) poses significant public health challenges, particularly for immunocompromised populations such as patients with cancer. However, misinformation poses a significant challenge during new outbreaks for patients with chronic diseases, as observed during the COVID-19 pandemic. Therefore, we aimed to assess perspectives and knowledge of patients with cancer on mpox and their willingness to receive mpox vaccination.
View Article and Find Full Text PDFExpert Rev Anticancer Ther
December 2024
Background: The prognostic role of preoperative carcinoembryonic antigen (CEA) in breast cancer is recognized, but the impact of postoperative CEA levels on survival in early breast cancer is uncertain.
Research Design And Methods: We conducted a retrospective study of 921 non-metastatic breast cancer patients treated at anonymized. Patients were categorized as normal (CEA ≤3 µg/L) or elevated (CEA >3 µg/L).